Skip to main content
Menu
US
US

LANCE® (lanthanide chelate excite) TR-FRET technology combines the benefits of Time Resolved Fluorescence (TRF) with those of Förster Resonance Energy Transfer (FRET) in a simple, highly-sensitive, and highly reproducible assay platform for detection, quantitation and screening in microplate format.

The use of long-lifetime fluorescent lanthanide chelates, rather than other fluorophores, allows for a delay in measurement between excitation and emissions, which occur simultaneously in standard fluorometric assays. Furthermore, FRET detection utilizes energy donor and energy acceptor fluorophore labels in solution to create a no-wash detection assay. By combining the benefits of TRF and FRET, LANCE TR-FRET offers a multitude of benefits over standard fluorometric detection:

  • Homogeneous assay format (no wash steps, no separation steps)
  • Reduced background leading to better S:B
  • Large stoke’s shift
  • Wider dynamic range
  • Extended signal stability
  • Increased sensitivity. Lower detection limits of 10 pg/mL compared to 100 pg/mL for standard fluorometric detection
  • Faster time to results

From biomarker detection assays, to cAMP/GPCR studies, to kinase and epigenetic assays, our LANCE and LANCE Ultra TR-FRET assays are sure to save you time and hassle.

16054_lance_valueprops800px.jpg


For research use only. Not for use in diagnostic procedures.

LANCE TR-FRET Assays

Explore our solutions

Target Area

Target area

Explore cell-based and biochemical assays by target area of interest, including cell and gene therapy, GPCRs, targeted protein degradation, and more.

Explore cell-based and biochemical assays by target area of interest, including cell and gene therapy, GPCRs, targeted protein degradation, and more.

  • Biologics screening and characterization: Explore assays for biologics screening, mechanism-of-action studies, and biomanufacturing.
  • Biomarker detection: Accurate detection and quantitation of molecular targets across serum, plasma, culture supernatants, cellular lysates, and other sample types.
  • Cell and gene therapy: Discover and advance cell and gene therapy research with bioanalytical immunoassays for CGT development.
  • Cytokines: Access a comprehensive range of cytokine assay kits, including interleukins, interferons, chemokines, tumor necrosis factors, and lymphokines.
  • Epigenetics: Leverage our epigenetics toolbox, designed to detect specific methylation and acetylation marks on histone peptide substrates.
  • GPCRs: Measure cAMP levels and track downstream protein phosphorylation with functional GPCR assays.
  • Protein kinases: Explore an extensive portfolio of protein phosphorylation assays, available in cell-based or biochemical no-wash formats.
  • Protein-protein interactions: Utilize highly sensitive assays to study protein interactions involved in a range of biological processes.
  • Targeted protein degradation: Monitor protein expression levels and characterize the mechanism of action using our total and phospho kits.
Therapeutic Area

Therapeutic area

Explore cell-based and biochemical assays by your therapeutic area of research, including oncology, neuroscience, metabolic diseases, and more.

Explore cell-based and biochemical assays by your therapeutic area of research, including oncology, neuroscience, metabolic diseases, and more.

  • Autoimmune diseases: Comprehensive reagents for autoimmune disease research, including rheumatoid arthritis, lupus, inflammatory bowel disease, multiple sclerosis, and more.
  • Obesity, diabetes, and metabolic diseases: Solutions for drug discovery in obesity, diabetes, and metabolic diseases, featuring assays for biomarker detection, protein analysis, and GPCR research.
  • Fibrosis: Ready-to-use assays for monitoring biomarkers, phosphoproteins, and transcription factors relevant to fibrotic disease research.
  • Immuno-oncology: Assays for studying immunity and immune cells, covering protein, biomarker, and cytokine detection, as well as cell toxicity and proliferation.
  • Oncology: A comprehensive oncology portfolio, including assays for cytokines, biomarkers, phospho-proteins, cell proliferation, cytotoxicity, and more.
  • Neuroscience: A wide range of neuroscience assays to support research in neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington's disease.
  • Virology: Assay technologies for viral studies, enabling assessment of viral life cycles and antiviral immune responses with streamlined workflows.
bg-element-listing-page bg-element-listing-page-mobile
Products & Services
Resource Library
Filters
Expand All|Collapse All
Product Type
Application
Brand
Cellular or Signaling Pathway
Detection Modality
Fluorophore
Host Species
Product Group
Target
Target Class
Target Species
Therapeutic Area
Sort by: Recommended
Recommended
Product Name A-Z
Product Name Z-A
Price - low to high
Price - high to low
1 - 25 of 205 Products and Services
Lance Ultra Detection Kit

The LANCE® Ultra Human Insulin Detection Kit is designed for detection and quantitation of human insulin in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1204C, TRF1204M
USD 1,242.22 - 16,442.42
LANCE Ultra Phospho-Protein

LANCE Ultra phospho-SLP-76 (Ser376) kits are designed for the detection of SLP76 (phosphorylated at S376) in cell lysates using a simple, homogeneous LANCE Ultra assay (no wash steps). This assay is compatible with both adherent and suspension cells.

Part Number: TRF4010C, TRF4010M
USD 2,256.68 - 10,197.60
Lance Ultra Detection Kit

The LANCE® Human CRP Detection Kit is designed for detection and quantitation of human C-reactive protein in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1233C, TRF1233M
USD 1,242.22 - 16,442.42
Lance Ultra Detection Kit

The LANCE® Ultra Mouse VEGF-A Detection Kit is designed for detection and quantitation of human CXCL1/GRO-α in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1520C, TRF1520M
USD 1,244.41 - 16,442.42
Lance Ultra Detection Kit

The LANCE® Ultra Human Albumin Detection Kit is designed for detection and quantitation of human albumin in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1294C, TRF1294M
USD 1,242.22 - 16,551.97
Lance Ultra Detection Kit

The LANCE® Ultra Human CXCL9/MIG Detection Kit is designed for detection and quantitation of human CXCL9/MIG in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1280C, TRF1280M
USD 1,200.91 - 16,442.42
Lance Ultra Detection Kit

The LANCE® Ultra Human MMP-3 Detection Kit is designed for detection and quantitation of human matrix metalloproteinase-3 in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1284C, TRF1284M
USD 1,244.41 - 16,442.42
Lance Ultra Detection Kit

The LANCE® Ultra Human IL-8 Detection Kit is designed for detection and quantitation of human interleukin 8 in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1224C, TRF1224M
USD 1,245.32 - 16,483.48
Lance Ultra Detection Kit

The LANCE® Ultra Human IFNγ Detection Kit is designed for detection and quantitation of human interferon gamma in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1217C, TRF1217M
USD 1,245.32 - 16,483.48
LANCE Ultra Phospho-Protein

LANCE Ultra Total eIF2α kits are designed for the detection of total eIF2α (phosphorylated and non-phosphorylated) in cell lysates using a simple, homogeneous LANCE Ultra assay (no wash steps). This assay can be used as a normalization assay for phospho-eIF2α detection, and is compatible with both adherent and suspension cells.

Part Number: TRF4023C, TRF4023M
USD 2,256.68 - 10,197.60
LANCE Ultra Phospho-Protein

LANCE Ultra phospho-eIF2A (Ser51) kits are designed for the detection of eIF2A (phosphorylated at S51) in cell lysates using a simple, homogeneous LANCE Ultra assay (no wash steps). This assay is compatible with both adherent and suspension cells.

Part Number: TRF4008C, TRF4008M
USD 2,256.68 - 10,197.60
Lance Ultra Detection Kit

The LANCE® Ultra Human MMP-10 Detection Kit is designed for detection and quantitation of human MMP-10 in cell culture media and cell supernatants using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF3000C, TRF3000M
USD 3,599.59 - 16,672.46
Lance Ultra Detection Kit

The LANCE® Ultra Residual DNA Contamination Detection Kit is designed for detection and quantitation of DNA contaminants in buffered solution and cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1331C, TRF1331M
USD 1,207.17 - 16,091.88
LANCE Ultra Phospho-Protein

LANCE Ultra phospho-ZAP-70 (Tyr319) kits are designed for the detection of phosphorylated ZAP-70 in cell lysates using a simple, homogeneous LANCE Ultra assay (no wash steps). This assay is compatible with both adherent and suspension cells.

Part Number: TRF4024C, TRF4024M
USD 2,256.68 - 10,197.60
Lance Ultra Detection Kit

The LANCE® Ultra Mouse CCL2/MCP-1α Detection Kit is designed for detection and quantitation of mouse Monocyte Chemoattractant Protein 1α in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1509C, TRF1509M
USD 1,245.32 - 16,483.48
Lance Ultra Detection Kit

The LANCE® Ultra Mouse IgG Detection Kit is designed for detection and quantitation of Mouse IgG in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1529C, TRF1529M
USD 1,242.22 - 16,551.97
Lance Ultra Detection Kit

The LANCE® Ultra Human TNFα Detection Kit is designed for detection and quantitation of human TNFα in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1208C, TRF1208M
USD 1,247.52 - 16,483.48
Lance Ultra Detection Kit

The LANCE® Ultra Human BCL-2 Detection Kit is designed for detection and quantitation of human Bcl-2 in buffered solution and cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1384C, TRF1384M
USD 1,244.41 - 16,442.42
Lance Ultra Detection Kit

Europium-labeled biotin for use in LANCE® TR-FRET assays.

Part Number: CR91-100
USD 1,550.61
Lance Ultra Detection Kit

The LANCE® Ultra Human IgG Detection Kit is designed for detection and quantitation of human IgG in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1205C, TRF1205M
USD 1,242.22 - 16,551.97
Lance Ultra Detection Kit

The LANCE® Ultra Human Frataxin Detection Kit is designed for detection and quantitation of human frataxin in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1322C, TRF1322M
USD 1,244.41 - 16,442.42
Lance Ultra Detection Kit

The LANCE® Ultra Mouse IL-6 Detection Kit is designed for detection and quantitation of murine IL-6 in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1504C, TRF1504M
USD 1,245.32 - 16,483.48
LANCE Ultra Phospho-Protein

LANCE Ultra phospho-STAT3 (Tyr705) kits are designed for the detection of phosphorylated STAT3 in cell lysates using a simple, homogeneous LANCE Ultra assay (no wash steps). This assay is compatible with both adherent and suspension cells.

Part Number: TRF4004C, TRF4004M
USD 2,256.68 - 10,197.60
LANCE Ultra Phospho-Protein

LANCE Ultra phospho-BTK (Tyr223) kits are designed for the detection of phosphorylated BTK in cell lysates using a simple, homogeneous LANCE Ultra assay (no wash steps). This assay is compatible with both adherent and suspension cells.

Part Number: TRF4021C, TRF4021M
USD 2,256.68 - 10,197.60
Lance Ultra Detection Kit

The LANCE® Ultra c-Myc Detection Kit is designed for detection and quantitation of c-Myc peptide tag in buffered solution and cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Part Number: TRF1111C, TRF1111M
USD 1,244.41 - 16,551.97
Filters
Expand All|Collapse All
Resource Type
Sort by: Resource Name A-Z
Resource Name A-Z
Resource Name Z-A
1 - 14 of 14 Resources
Application Note
Application Note
Characterizing chemokine receptor inhibitors with AlphaLISA SureFire Ultra, Alpha SureFire Ultra Multiplex and LANCE Ultra cAMP assays

The measurement of protein phosphorylation is a useful tool for measuring the modulation of receptor activation by both antibodies and small molecules. CCR7 and CXCR2 receptors, which are expressed in immune cells and are therapeutic targets for disorders like lupus erythematosus, adult leukemia, lymphomas, chronic obstructive pulmonary disease (COPD), and sepsis. AlphaLISA ™ SureFire ® Ultra ™ and Alpha SureFire ® Ultra ™ Multiplex assays are automation-friendly, applicable to both small and large-scale screens, and can assess phosphorylation status in complex matrices. The LANCE Ultra cAMP assay is measures cyclic AMP (cAMP) produced upon modulation of adenylyl cyclase activity by G-protein coupled receptors (GPCRs). This application note demonstrates how the SureFire Ultra and LANCE Ultra cAMP assays can be used for measuring inhibitors to CCR7 and CXCR2 cell surface receptors using a cellular model system where these receptors are overexpressed in CHO cells. The assays were optimized to measure receptor blockage and assayed receptor activity modulation by detecting ERK and AKT phosphorylation status and cAMP modulation. For more details, download the application note!

Application Note
Application Note
Developing a LANCE TR-FRET assay for screening PD-1 and PD-L1 binding inhibitors.

Here, we demonstrate the utility and benefits of using LANCE Ultra TR-FRET assay technology for identifying and characterizing PD-1/PD-L1 binding inhibitors.

Guide
Guide
Download your guide about neurodegenerative diseases

Emerging pathways to neuroinflammation and neurodegeneration Neurodegenerative diseases, such as amyotrophic lateral sclerosis, Parkinson's disease, or Alzheimer's disease, occur as a result of neuroinflammation and neurodegenerative progression. For the moment, these diseases are incurable. However, as research progresses, many similarities between these diseases have been found at a sub-cellular level. Review the fundamentals of the neuroinflammation process Learn from a cutting-edge research report Detailed insight into neurodegenerative diseases

Whitepaper
Whitepaper
Epigenetic modifications and how they relate to cancer development and therapy

Epigenetic modifications in cancer The field of epigenetics has revealed revolutionary methods for understanding heredity. Epigenetic modifications can create new phenotypes that are inherited by later generations, without modifying the inherited DNA sequence itself. In this white paper, you’ll learn: The general description of the three types of epigenetic modifications How these three types of epigenetic modifications play diverse roles in tumorigenesis and cancer progression The promising future of epigenetics in cancer

Guide
Guide
Finding the pathway to assay optimization is easy

Comprehensive Kinase and Antibody Selection for LANCE Ultra Assays Our comprehensive guide helps you identify and utilize kinases efficiently. It includes tested commercial kinase vendors and common aliases for easy reference. The guide lists the best performing ULight™ substrates for each enzyme, with signal to background (S/B) ratios provided under fixed conditions. Additionally, it helps you find the corresponding Europium-labeled anti-phospho antibody for your chosen substrate, essential for your LANCE Ultra assay. It offers two testing kits: the KinaSelect Ser/Thr Kit (TRF0300-C) with 5 ULight-labeled substrates and matching antibodies, and the KinaSelect TK Kit (TRF0301-D) with 1 ULight-labeled substrate and matching antibody. For research use only. Not for use in diagnostic procedures.

Brochure
Brochure
GPCRs: the pathway to discovery

G protein coupled-receptors (GPCRs) are one of the most intensively studied drug targets, with up to one-third of all marketed therapeutics acting by binding to GPCRs. Therapies that target GPCRs include both agonist and antagonists that are used in the treatment of disease in nearly every major organ system and hold significance in several therapeutic areas, such as cardiovascular diseases, neurosciences, respiratory diseases, metabolic disorders, oncology, and rare diseases. We know the importance of furthering GPCR research - and we answer the call with application notes, white papers, and end-to-end solutions including reagents, instruments, and tools for all aspects of research into today’s most promising drug target. For research use only. Not for use in diagnostic procedures.

Technical Note
Technical Note
How to access true Kd values in Protein-Protein Interaction assays

Investigate the dynamics of Interactions Kinetic values are of importance for characterizing protein-protein interactions. Studying them brings insight regarding macromolecule binding. Accessing kinetic values is therefore important. This application note dives deep into the topic to provide key guideline and experiments for determining true Kd values in protein-protein interaction assays with HTRF. Benefit from an expert's insight on: Handling HTRF data Determining Kd Investigating Prot-Prot Interactions

Guide
Guide
Improving immunotherapy by targeting the tumor stroma

Guide to How Cellular Actors of the Tumor Microenvironment Challenge Immunotherapies Since the early 2000s, significant scientific breakthroughs have been made to better understand the complexity of the tumor microenvironment (TME) and its implication in shaping the response to cancer immunotherapy. It is now clear that the TME is one of the main hallmarks of cancer. Therefore, one of the major research challenges is identifying key pathways and factors in the TME that can be targeted to enhance the efficacy of immunotherapies. This guide focuses on the implication of cancer-associated fibroblasts (CAFs) and tumor associated macrophages (TAMs) on cancer immunotherapy. As master regulators of the tumor stroma, CAFs and TAMs define the immediate environment of cancer cells, and this parameter is critical for immunotherapeutic strategies that rely on immune cells having physical and chemical access to tumors. Download this guide to get insight on: The implication of CAFs and TAMs in immunotherapy How innovative tools can facilitate the study of tissue fibrosis and accelerate the identification of effective drugs

Product Info
Product Info
LANCE and LANCE Ultra TR-FRET technology product list

LANCE™ Ultra TR-FRET is a no-wash proximity assay technology that combines the benefits of time resolution (TR) with fluorescence resonance energy transfer (FRET) principles by using energy donor and energy acceptor fluorophore labels. For research use only. Not for use in diagnostic procedures.

Guide
Guide
LANCE Ultra cAMP Assay development guidelines

The LANCE™ Ultra cAMP Assay Development Guidelines provide comprehensive instructions for the quantitative determination of cyclic adenosine monophosphate (cAMP) in cell lysate and cellular membrane samples. This guide details the assay principle, reagent preparation, protocols for cell preparation, and assay development workflow, emphasizing the assay’s sensitivity and robustness for high-throughput screening (HTS) applications. For research use only. Not for use in diagnostic procedures.

Application Note
Application Note
LANCE Ultra TR-FRET-based detection and modulation of phosphorylated STAT3 levels in human cells.

STAT3 is a particularly important therapeutic target since it is constitutively active in a range of cancer cells lines and human tumors. Therefore, fast and easy methods for screening of inhibitors of STAT3 activation are highly desirable.

Application Note
Application Note
Measurement of p38/MAPK Activity Using LANCE

This note presents a method to evaluate inhibitors of p38 kinase activity using LANCE. We are measuring energy transfer from a Eu-labeled antibody to a fluorophore-conjugated antibody binding to the GST portion of the fusion substrate

Guide
Guide
Protein degradation awareness in a single guide

An in-depth review of molecular and cellular pathways The maintenance of proteostasis, the biological mechanisms that control the fate of a protein from synthesis to degradation, is ensured by complex and interconnected pathways controlling protein abundance, turnover, folding, functions, subcellular localization, and ultimate degradation. Impaired proteostasis can lead to the accumulation of damaged or aggregated proteins, or conversely, to excessive protein degradation. Proteostasis is thus involved in pathologies such as cancer, autoimmune diseases, and neurodegenerative disorders. This protein degradation booklet helps scientists and researchers appreciate and navigate the diversity of molecular pathways associated with protein degradation. Check out this exclusive guide that includes: Key information about the ubiquitin structure, function, and regulation The cellular and molecular understandings on proteasome and autophagy degradation machinery An overview of current therapeutic strategies, as well as the promising PROTAC approach to specifically target protein degradation

Guide
Guide
The ultimate guide to PPI assays with HTRF

Your dream assay does not exist yet? Create it! This guide will provide you with tools to help you develop your very own protein:protein interaction assays for your research using HTRF™. Detailed steps, microplate plans, optimization procedures and data processing methods: let yourself be guided along the way to creating the assays for your experiments. Features Information relative to reagents, buffers and instrument handling Detailed guidelines and matrices to build, optimize and analyze your own assays Extensive example from our R&D to provide support

Questions?
We're here to help.

Contact us